COVID-19: Older drugs for a novel disease—Chloroquine, hydroxychloroquine, and possible Pentoxifylline—set to start the second innings?
Pugazhenthan Thangaraju1, Meenalotchini P Gurunthalingam1, Shobanbabu Varthya2, Sajitha Venkatesan3, Eswaran Thangaraju4
1 Department of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India 2 Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India 3 Department of Microbiology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India 4 Associate Professor, Department of EEE, AKT Memeorial College of Engineering and Technology, Kallakurichi, Tamil Nadu, India
Correspondence Address:
Dr. Pugazhenthan Thangaraju Assistant professor, Department of Pharmacology, All India Institute of Medical Sciences, Raipur - 492 099, Chhattisgarh India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jfmpc.jfmpc_422_20
|